UW18110
OPEN TO ACCRUAL
P I study OAR based dose escalated SBRT w/ real time adaptive MRI guidance liver mets
NCI10608
OPEN TO ACCRUAL
PII Durvalumab w/ Gem + Cis as Neoadjuvant therapy for high risk resectable intrahepatic cholangio
UW24051
OPEN TO ACCRUAL
Phase 1/2 Basket Study of MK-2870 in GI Cancers
UW24098
OPEN TO ACCRUAL
Ph 1/2 Study to Evaluate Safety and Efficacy of Patritumab Deruxtecan in Gastrointestinal Cancers
INT22-09-01
OPEN TO ACCRUAL
A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer